Avidity Biosciences Ownership | Who Owns Avidity Biosciences?


OverviewForecastRevenueFinancialsChart

Avidity Biosciences Ownership Summary


Avidity Biosciences is owned by 32.09% institutional investors, 5.18% insiders, and 62.73% retail investors. Fmr is the largest institutional shareholder, holding 13.38% of RNA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.23% of its assets in Avidity Biosciences shares.

RNA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAvidity Biosciences32.09%5.18%62.73%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.51M13.38%$480.10M
Rtw investments, lp8.81M10.10%$359.76M
Blackrock8.62M9.89%$352.23M
Price t rowe associates inc /md/11.04M8.95%$321.13M
Blackrock funding, inc. /de9.93M8.05%$288.83M
Vanguard group9.43M7.64%$274.28M
Wellington management group llp8.11M6.57%$235.73M
Avoro capital advisors7.50M6.08%$218.10M
Janus henderson group7.05M5.72%$205.13M
Ra capital management6.30M5.11%$183.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management420.87K10.48%$12.24M
Rtw investments, lp8.81M5.57%$359.76M
Propel bio management178.50K5.16%$5.19M
Casdin capital2.04M3.96%$59.47M
Boxer capital1.73M3.72%$70.56M
Silverarc capital management543.65K3.46%$15.81M
Avoro capital advisors7.50M3.08%$218.10M
Bioimpact capital702.98K2.90%$20.44M
Ra capital management6.30M2.44%$183.22M
Cormorant asset management, lp1.05M1.68%$30.53M

Top Buyers

HolderShares% AssetsChange
Blackrock8.62M0.01%2.46M
Janus henderson group7.05M0.10%2.16M
Polar capital1.11M0.27%1.11M
Wellington management group llp8.11M0.04%1.08M
Rtw investments, lp8.81M5.57%836.57K

Top Sellers

HolderShares% AssetsChange
Cowen and company---5.13M
Nuveen asset management352.50K0.00%-706.06K
5am venture management---665.55K
D. e. shaw558.97K0.01%-549.68K
Lord, abbett---539.21K

New Positions

HolderShares% AssetsChangeValue
Polar capital1.11M0.27%1.11M$45.51M
Norges bank724.79K0.00%724.79K$21.08M
Artal group655.55K0.68%655.55K$26.78M
Finepoint capital lp391.30K0.69%391.30K$11.38M
Qube research223.76K0.01%223.76K$6.51M

Sold Out

HolderChange
Hollencrest capital management-10.00
Park place capital-12.00
Nelson, van denburg & campbell wealth management group-15.00
Capital performance advisors llp-21.00
Cwm-22.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024106-57.77%39,596,419-68.40%320.31%62-60.00%30-52.38%
Sep 30, 202425026.26%125,295,28411.90%1010.62%15419.38%6328.57%
Jun 30, 202419822.98%111,975,61125.39%1281.22%12944.94%49-
Mar 31, 20241619.52%89,302,00417.64%1020.95%8914.10%496.52%
Dec 31, 20231472.08%75,911,779-7.12%1030.85%78-2.50%4617.95%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S5.05M4.23%100.91K
Fidelity Growth Compy Commingled Pl O4.86M4.11%-69.00K
US Small-Cap Growth II Equity Comp4.43M3.71%-51.14K
T. Rowe Price New Horizons4.43M3.71%-
Vanguard Total Stock Mkt Idx Inv3.54M2.97%8.62K
Fidelity Growth Company Fund3.49M2.92%-40.23K
iShares Russell 2000 ETF2.89M2.41%-56.58K
T. Rowe Price Health Sciences2.44M2.05%-200.29K
Vanguard Health Care Inv2.35M1.97%-
SPDR® S&P Biotech ETF1.90M1.58%14.32K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 11, 2025Flanagan W. Michael Chief Scientific OfficerSell$602.61K
Mar 03, 2025Gallagher Kathleen P. Chief Program OfficerSell$172.81K
Feb 03, 2025Gallagher Kathleen P. Chief Program OfficerSell$188.92K
Jan 21, 2025LEVIN ARTHUR A-Sell$53.54K
Jan 21, 2025MacLean Michael F Chief Financial OfficerSell$46.38K

Insider Transactions Trends


DateBuySell
2025 Q1-18
2024 Q4-14
2024 Q3-14
2024 Q2-18
2024 Q1-12

RNA Ownership FAQ


Who Owns Avidity Biosciences?

Avidity Biosciences shareholders are primarily institutional investors at 32.09%, followed by 5.18% insiders and 62.73% retail investors. The average institutional ownership in Avidity Biosciences's industry, Biotech Stocks , is 69.02%, which Avidity Biosciences falls below.

Who owns the most shares of Avidity Biosciences?

Avidity Biosciences’s largest shareholders are Fmr (16.51M shares, 13.38%), Rtw investments, lp (8.81M shares, 10.10%), and Blackrock (8.62M shares, 9.89%). Together, they hold 33.37% of Avidity Biosciences’s total shares outstanding.

Does Blackrock own Avidity Biosciences?

Yes, BlackRock owns 9.89% of Avidity Biosciences, totaling 8.62M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 352.23M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 39.84% change.

Who is Avidity Biosciences’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Avidity Biosciences’s biggest shareholder by percentage of total assets invested, with 10.48% of its assets in 420.87K Avidity Biosciences shares, valued at 12.24M$.

Who is the top mutual fund holder of Avidity Biosciences shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Avidity Biosciences shares, with 4.23% of its total shares outstanding invested in 5.05M Avidity Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools